|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9784
|
|
pubmed:dateCreated |
2011-6-27
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
pubmed-author:BrodieBruce RBR,
pubmed-author:DangasGeorgeG,
pubmed-author:DudekDariuszD,
pubmed-author:FahyMartinM,
pubmed-author:GershBernard JBJ,
pubmed-author:GuagliumiGiulioG,
pubmed-author:HORIZONS-AMI Trial Investigators,
pubmed-author:HartmannFranzF,
pubmed-author:KornowskiRanR,
pubmed-author:MehranRoxanaR,
pubmed-author:PariseHelenH,
pubmed-author:PerugaJan ZJZ,
pubmed-author:PocockStuart JSJ,
pubmed-author:StoneGregg WGW,
pubmed-author:WitzenbichlerBernhardB,
pubmed-author:WongS ChiuSC
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
25
|
|
pubmed:volume |
377
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2193-204
|
|
pubmed:meshHeading |
pubmed-meshheading:21665265-Angioplasty, Balloon,
pubmed-meshheading:21665265-Combined Modality Therapy,
pubmed-meshheading:21665265-Confidence Intervals,
pubmed-meshheading:21665265-Dose-Response Relationship, Drug,
pubmed-meshheading:21665265-Drug Administration Schedule,
pubmed-meshheading:21665265-Drug Therapy, Combination,
pubmed-meshheading:21665265-Drug-Eluting Stents,
pubmed-meshheading:21665265-Electrocardiography,
pubmed-meshheading:21665265-Female,
pubmed-meshheading:21665265-Follow-Up Studies,
pubmed-meshheading:21665265-Heparin,
pubmed-meshheading:21665265-Hirudins,
pubmed-meshheading:21665265-Humans,
pubmed-meshheading:21665265-Kaplan-Meier Estimate,
pubmed-meshheading:21665265-Male,
pubmed-meshheading:21665265-Myocardial Infarction,
pubmed-meshheading:21665265-Paclitaxel,
pubmed-meshheading:21665265-Peptide Fragments,
pubmed-meshheading:21665265-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:21665265-Prospective Studies,
pubmed-meshheading:21665265-Recombinant Proteins,
pubmed-meshheading:21665265-Stents,
pubmed-meshheading:21665265-Survival Analysis,
pubmed-meshheading:21665265-Time Factors,
pubmed-meshheading:21665265-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.
|
|
pubmed:affiliation |
New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY 10022, USA. gs2184@columbia.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
